Medicine Matters diabetes
1.59K subscribers
15:11
How real-world studies complement randomized controlled trials | Jean-Pierre Riveline
Medicine Matters diabetes
355 views • 1 year ago
7:12
Initiating GLP-1 receptor agonists: Managing side effects | Nicola Milne
Medicine Matters diabetes
3K views • 1 year ago
8:47
SURMOUNT-1: Heralding a ‘golden age’ for obesity treatment | Louis Aronne
Medicine Matters diabetes
2.2K views • 1 year ago
18:27
Ramadan fasting, feasts, and type 2 diabetes | Shehla Shaikh
Medicine Matters diabetes
438 views • 2 years ago
22:15
Ramadan and type 1 diabetes: Supporting religious fasting | Simon Heller and Shehla Shaikh
Medicine Matters diabetes
621 views • 2 years ago
2:56
Addressing the challenges of Ramadan for people with diabetes | Sanjay Kalra
Medicine Matters diabetes
210 views • 2 years ago
2:58
Why type 2 diabetes is so challenging to manage in children | Phil Zeitler
Medicine Matters diabetes
122 views • 2 years ago
2:04
Treatment priorities in children with type 2 diabetes | Julian Hamilton-Shield
Medicine Matters diabetes
115 views • 2 years ago
2:15
When to screen for type 2 diabetes in children | AG Unnikrishnan
Medicine Matters diabetes
78 views • 2 years ago
5:21
EMPULSE: The ‘missing link’ for empagliflozin in heart failure | Adriaan Voors
Medicine Matters diabetes
1.9K views • 2 years ago
8:12
What is hypoglycemia-associated autonomic failure? | Sambit Das
Medicine Matters diabetes
1K views • 2 years ago
9:35
PRESERVED-HF: Support for dapagliflozin to improve HFpEF health status | Mikhail Kosiborod
Medicine Matters diabetes
1K views • 2 years ago
5:33
SAFES summit 2021: Using modern sulfonylureas | Mohammad Wali Naseri
Medicine Matters diabetes
113 views • 2 years ago
38:55
Time to reconsider the person with shortness of breath: EMPEROR-Preserved
Medicine Matters diabetes
926 views • 2 years ago
7:43
SURPASS-4: Tirzepatide as an alternative to insulin glargine in type 2 diabetes | Stefano Del Prato
Medicine Matters diabetes
1.1K views • 2 years ago
1:08
Time to reconsider the person with shortness of breath: EMPEROR-Preserved
Medicine Matters diabetes
51 views • 2 years ago
4:04
The ADA/EASD type 1 diabetes consensus: Comprehensive and up to date | Parth Narendran
Medicine Matters diabetes
179 views • 2 years ago
10:04
How will the TriMaster results impact patient-centered care? | Pinar Topsever
Medicine Matters diabetes
113 views • 2 years ago
9:53
Management of type 1 diabetes: ADA/EASD consensus report | Anne Peters
Medicine Matters diabetes
531 views • 2 years ago
4:12
The HARPdoc intervention for people with poor hypoglycemia awareness | Stephanie Amiel
Medicine Matters diabetes
161 views • 2 years ago
7:40
The TriMaster study of individualized medicine in type 2 diabetes | Andrew Hattersley
Medicine Matters diabetes
396 views • 2 years ago
7:22
FIGARO: Where will finerenone fit into diabetic kidney disease treatment | David Wheeler
Medicine Matters diabetes
4.9K views • 2 years ago
18:00
DKD treatment update: SGLT2 inhibitors and finerenone | Ian de Boer & Amrit Lamba
Medicine Matters diabetes
5.6K views • 2 years ago
8:27
EMPEROR-Preserved: Diabetes medication becomes first effective HFpEF therapy | Stefan Anker
Medicine Matters diabetes
1.8K views • 2 years ago
4:43
EMPEROR-Preserved: The implications for primary care | Kevin Fernando
Medicine Matters diabetes
1.1K views • 2 years ago
2:25
A Collaborative Community to address suicide risk in diabetes | Katharine Barnard-Kelly
Medicine Matters diabetes
227 views • 2 years ago
15:34
An update on COVID-19 and diabetes | Stefan Bornstein
Medicine Matters diabetes
367 views • 2 years ago
3:54
ADA 2021 – What do the GRADE results mean for clinical practice? | Patrick Holmes
Medicine Matters diabetes
745 views • 2 years ago
3:58
ADA 2021 – The SURPASS trials so far: Tirzepatide, semaglutide, and type 2 diabetes | John Wilding
Medicine Matters diabetes
4.7K views • 2 years ago
5:13
ADA 2021– SURPASS-5: Tirzepatide in people with insulin-dependent type 2 diabetes | Michelle Welch
Medicine Matters diabetes
1.8K views • 2 years ago
Load More